BARDA is seeking $200K Challenge entries in the following areas of interest:

• Repurpose existing therapeutics as MCMs against chemical threats (cyanide, opioids, nerve agents, chlorine, sulfur mustard, etc.).
• Novel platform technologies and instrumentation for on-demand detection of multiple biochemical health markers
• Digital health diagnostic tools that can augment existing medical countermeasures against health security threats
• Therapies aimed at fortifying and restoring balance to the body’s defense mechanisms with a preference for multiplexed biochemical assays
• Novel technologies to sustain healthy oxygenation levels in ARDS patients
• Development of On Demand Vaccine Manufacturing technologies/systems for distributed vaccine production at or near the point-of-service, with a particular focus on nucleic acid-based vaccines
• Host-based diagnostics
• Repurposing existing FDA-approved and late-stage development therapeutics as potential MCMs for radiological and nuclear events

Learn more.